Mind Medicine Current Ratio vs. Cash And Equivalents

MNMD Stock  USD 8.17  0.09  1.09%   
Based on the measurements of profitability obtained from Mind Medicine's financial statements, Mind Medicine may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in December. Profitability indicators assess Mind Medicine's ability to earn profits and add value for shareholders.
 
Current Ratio  
First Reported
2010-12-31
Previous Quarter
3.22123674
Current Value
3.06
Quarterly Volatility
9.6067567
 
Credit Downgrade
 
Yuan Drop
 
Covid
At present, Mind Medicine's Graham Net Net is projected to increase slightly based on the last few years of reporting. The current year's Interest Debt Per Share is expected to grow to 0.38, whereas Book Value Per Share is forecasted to decline to 1.90.
For Mind Medicine profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Mind Medicine to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Mind Medicine utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Mind Medicine's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Mind Medicine over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
For information on how to trade Mind Stock refer to our How to Trade Mind Stock guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mind Medicine. If investors know Mind will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mind Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.71)
Return On Assets
(0.25)
Return On Equity
(0.55)
The market value of Mind Medicine is measured differently than its book value, which is the value of Mind that is recorded on the company's balance sheet. Investors also form their own opinion of Mind Medicine's value that differs from its market value or its book value, called intrinsic value, which is Mind Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mind Medicine's market value can be influenced by many factors that don't directly affect Mind Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mind Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mind Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mind Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Mind Medicine Cash And Equivalents vs. Current Ratio Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Mind Medicine's current stock value. Our valuation model uses many indicators to compare Mind Medicine value to that of its competitors to determine the firm's financial worth.
Mind Medicine is regarded third in current ratio category among its peers. It is regarded fourth in cash and equivalents category among its peers creating about  7,629,149  of Cash And Equivalents per Current Ratio. At present, Mind Medicine's Current Ratio is projected to decrease significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Mind Medicine by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Mind Cash And Equivalents vs. Current Ratio

Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Mind Medicine

Current Ratio

 = 

Current Asset

Current Liabilities

 = 
13.86 X
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Mind Medicine

Cash

 = 

Bank Deposits

+

Liquidities

 = 
105.74 M
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).

Mind Cash And Equivalents Comparison

Mind Medicine is currently under evaluation in cash and equivalents category among its peers.

Mind Medicine Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Mind Medicine, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Mind Medicine will eventually generate negative long term returns. The profitability progress is the general direction of Mind Medicine's change in net profit over the period of time. It can combine multiple indicators of Mind Medicine, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income343 K513.6 K
Interest Income839.5 K881.5 K
Operating Income-93.9 M-89.2 M
Income Before Tax-95.7 M-90.9 M
Net Loss-51.1 M-53.7 M
Net Loss-95.7 M-90.9 M
Total Other Income Expense Net-1.9 M-1.8 M
Income Tax Expense-8.6 M-8.2 M
Net Interest Income4.8 M5.1 M
Net Loss-76.8 M-80.6 M
Non Operating Income Net Other11 M11.5 M
Change To Netincome6.6 M6.2 M
Net Loss(2.44)(2.57)
Income Quality 0.67  0.44 
Net Income Per E B T 0.96  1.03 

Mind Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Mind Medicine. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Mind Medicine position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Mind Medicine's important profitability drivers and their relationship over time.

Use Mind Medicine in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Mind Medicine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mind Medicine will appreciate offsetting losses from the drop in the long position's value.

Mind Medicine Pair Trading

Mind Medicine Pair Trading Analysis

The ability to find closely correlated positions to Mind Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mind Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mind Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mind Medicine to buy it.
The correlation of Mind Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mind Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mind Medicine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Mind Medicine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Mind Medicine position

In addition to having Mind Medicine in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Market Neutral Funds Thematic Idea Now

Market Neutral Funds
Market Neutral Funds Theme
Funds or Etfs that invest in both long and short positions of different entities to enhance returns from broad market movements over time. The Market Neutral Funds theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Market Neutral Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Mind Medicine is a strong investment it is important to analyze Mind Medicine's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mind Medicine's future performance. For an informed investment choice regarding Mind Stock, refer to the following important reports:
Check out Correlation Analysis.
For information on how to trade Mind Stock refer to our How to Trade Mind Stock guide.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
To fully project Mind Medicine's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Mind Medicine at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Mind Medicine's income statement, its balance sheet, and the statement of cash flows.
Potential Mind Medicine investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Mind Medicine investors may work on each financial statement separately, they are all related. The changes in Mind Medicine's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Mind Medicine's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.